Skip to main content

Table 3 Tumor staging

From: Prioritization of head and neck cancer patient care during the COVID-19 pandemic: a retrospective cohort study

 

Pre-pandemic group (n = 132)

Pandemic group (n = 133)

p-value

Tumor size

 T1/T2 (%)

50 (52.6)

47 (47.0)

0.432

 T3/T4 (%)

45 (47.4)

53 (53.0)

0.432

Lymph nodes

 N0 (%)

42 (46.2)

48 (46.2)

0.465

 N1 (%)

21 (23.1)

27 (26)

0.485

 N2 (%)

20 (22)

24 (23.1)

0.805

 N3 (%)

8 (8.8)

5 (4.8)

0.887

Metastasis

 M1 (%)

5 (5.1)

9 (8.1)

0.386

  1. *Significant difference (p < .05)